Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2026-03-03 00:00:00 ET · period of report 2026-03-01 · accession 0001919170-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | 2026-03-01 | EBS | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $8.15 | -313 | 112.3K | -0.3% | -$2,551 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-01 | F | D | 313 | $8.15 | 112,307 | D | — | — | (F1) Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units. |